source
- Zealand and Roche report positive Phase 2 results for amylin drug petrelintide in obesity and diabetesZealand Pharma and Roche announced topline results from a Phase 2 trial of their amylin analogue petrelintide in patients with obesity and type 2 diabetes. The interim data showed that participant…
- Tailored breast cancer care for older women gains momentum as researchers highlight age-specific tumor differencesOlder women represent a large share of breast cancer diagnoses, with nearly half of cases occurring in patients 65 or older and about one-fifth in those 75 and older. Despite these numbers, clinic…